I agree but I believe the CEO is trying to be as transparent as possible and give full disclosure. He just sold some institutions $100 million in stock at $4 and doesn't want to appear as if he was holding this information back.
I'm not big on conspiracies but perhaps JAKoff lobby with their billions at stake caught the ear of some FDAers
bjl, I agree completely. I tire of the non-stop conspiracies about the "big boys", market makers and the naked shorts. However, this smells of INCY's $10 billion market cap riding on JAK that Teferri says he won't give to patients in addition other Pharmas that have pumped billions into JAK
My liver should recover once the bottle is empty.
Maybe we can start pumping Tom Brokaw even though we know his type of cancer has not been treated at Mayo in their Imetelstat trial.
The study was updated on March 10 and the reason is "due to contact issues".
That's a fact
Or maybe he escaped from the cold Minnesota weather and is sitting on a beach with an umbrella drink.
Rational, every yahoo message board is filled with conspiracies about manipulation every time a stock's price doesn't move as desired. There's market makers, naked shorts, big pharma, institutions all in cahoots to suppress and bring down the PPS. It's laughable.
It's not a negative.I'm just suggesting Chip is going to do a deal and has no intention to bring Imetelstat to market on its own. You don't reduce office space if you're preparing to market a drug
A GRNVAC2 trial was slated to start in the UK and funded outside Geron prior to Okarma's departure. I recently saw a reference from Okarma about having a GRNVAC2 trial in Europe so it might be back on if they have the funds.... And that's a big if. I'm guessing institutions will be reluctant to throw more money his way.
Just read the SEC filing you reference. They are reducing office space from 31k to 24k. I guess this means they don't plan on growing and being around for a long time... hint .. hint.
"Landlord and Tenant are parties to that certain Office Lease Agreement dated February 29th, 2012 (the"Lease"), the First Amendment dated January 10, 2014 (the “ First Amendment ”), and the Second Amendment dated January 31 st , 2014 (the “ Second Amendment ).Collectively, the Lease, First Amendment and Second Amendment are referred to herein as the “ Lease ”. Pursuant to the Lease, Landlord has leased to Tenant (i) space currently containing approximately 30,174 rentable square feet as set forth on EXHIBIT A to the Lease (the "Premises") on the second floor of the building, known as suites 2020, 2044, 2055, 2069 and 2070, located at 149 Commonwealth Dr., Menlo Park, CA 94025 (the "Building").
The Lease by its terms is due to expire on July 12, 2014,("Termination Date"),and the parties now desire to extend the term of the Lease, change the rental rate, reduce the rentable area, provide a tenant improvement allowance and include one option to extend the lease term, all on the following terms and conditions."
They had PRs in sarcomas in the Phase 1 trial. They are solid tumors but bone marrow base where Imetelstat seems to go.
While I don't agree with some of what you say. I think you are short changing the potential of Imetelstat many other blood cancer indications. Joanie on the other hand is a pumping fool that doesn't have a clue
PPS is the most important thing for people bad at math. Market cap is the real value of a company and $180 million for a phase 1 biotech like ACTC is not bad.
Rational, I agree that put options can play an important role in option strategies. However, buying them to protect against a Geron drop seems like a waste of money to me. You would be better off reducing your position in shares by the amount you spend on puts which are only good for a short time and will likely expire worthless. If you lack that much confidence in Geron's near term success then sell or reduce your position and come back later.
You probably are wasting your time here trying to discuss put options as many of the most prolific posters have no clue how they work and associate it with being the same as shorting
Chip has been saying June for a long time. A slip of 1 month to July is ok with me. I assume Tefferi knows it's July since he is the lead investigator for phase 2.
I'm not sure where you got April from. I think irishtrader has said April but maybe that is when her husband can be treated at a closer by phase 2 center and not necessarily the start of Geron's phase 2.
Not true. Dr. Glass who was involved in the phaseI study is conducting a new trial at Emory minus the stem cells. That study is fully enrolled and hopefully we get some results soon